Merial Gains Exclusive License For Staphylococcal Vaccine
January 10, 2011
Centegen Inc. has granted Merial Ltd. of Duluth, Ga., an exclusive license for its staphylococcal vaccine for veterinary applications. Merial will develop and globally commercialize the CEN-102 vaccine, which is designed to reduce staphylococcal infections in ruminant animals. Specific terms of the transaction were not disclosed, but include license fees, milestone payments and tiered royalties… Continue reading...